Myocardial alterations in diabetes and hypertension

Area of Science:

• Cardiology
• Endocrinology
• Pathophysiology

Background:

• Diabetes mellitus is characterized by hyperglycemia, increasing cardiovascular risks.
• Diabetic patients exhibit susceptibility to atherosclerosis, cardiac, and cerebral complications.
• Diabetic cardiomyopathy, distinct from coronary artery disease, presents a long-recognized but poorly understood cardiac dysfunction.

Purpose of the Study:

• To review evidence for and against a purely metabolic etiology of diabetic cardiomyopathy.
• To examine the synergistic role of diabetes and hypertension in causing cardiac structural damage and ventricular dysfunction.
• To explore the potential impact of microvascular injury and therapeutic interventions on diabetic cardiomyopathy.

Main Methods:

• Review of existing clinical and experimental evidence.
• Analysis of studies investigating the interplay between diabetes, hypertension, and cardiac structure.
• Examination of findings related to microvascular function and therapeutic agents in experimental models and clinical studies.

Main Results:

• Evidence suggests diabetes and hypertension may jointly induce cardiac structural damage, leading to ventricular dysfunction and heart failure.
• Metabolic derangements of diabetes combined with hypertension-associated vascular abnormalities may cause microvascular-induced tissue injury.
• Experimental models show potential benefits of vasodilating calcium channel blockers and ACE inhibitors in mitigating tissue pathology and mortality.

Conclusions:

• Diabetic cardiomyopathy pathogenesis is complex, potentially involving the combined effects of diabetes and hypertension.
• Microvascular injury may play a significant role in the development of diabetic cardiomyopathy.
• Therapeutic strategies targeting microcirculatory flow and hypertension control may be crucial for preventing and treating diabetic cardiomyopathy, alongside metabolic control.